These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Evaluation of a prime-boost vaccine schedule with distinct adenovirus vectors against malaria in rhesus monkeys. Rodríguez A; Mintardjo R; Tax D; Gillissen G; Custers J; Pau MG; Klap J; Santra S; Balachandran H; Letvin NL; Goudsmit J; Radosević K Vaccine; 2009 Oct; 27(44):6226-33. PubMed ID: 19686691 [TBL] [Abstract][Full Text] [Related]
6. Systems analysis of protective immune responses to RTS,S malaria vaccination in humans. Kazmin D; Nakaya HI; Lee EK; Johnson MJ; van der Most R; van den Berg RA; Ballou WR; Jongert E; Wille-Reece U; Ockenhouse C; Aderem A; Zak DE; Sadoff J; Hendriks J; Wrammert J; Ahmed R; Pulendran B Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2425-2430. PubMed ID: 28193898 [TBL] [Abstract][Full Text] [Related]
7. Heterologous prime-boost immunization in rhesus macaques by two, optimally spaced particle-mediated epidermal deliveries of Plasmodium falciparum circumsporozoite protein-encoding DNA, followed by intramuscular RTS,S/AS02A. Walsh DS; Gettayacamin M; Leitner WW; Lyon JA; Stewart VA; Marit G; Pichyangkul S; Gosi P; Tongtawe P; Kester KE; Holland CA; Kolodny N; Cohen J; Voss G; Ballou WR; Heppner DG Vaccine; 2006 May; 24(19):4167-78. PubMed ID: 16574282 [TBL] [Abstract][Full Text] [Related]
8. The path of malaria vaccine development: challenges and perspectives. Arama C; Troye-Blomberg M J Intern Med; 2014 May; 275(5):456-66. PubMed ID: 24635625 [TBL] [Abstract][Full Text] [Related]
9. Priming with an adenovirus 35-circumsporozoite protein (CS) vaccine followed by RTS,S/AS01B boosting significantly improves immunogenicity to Plasmodium falciparum CS compared to that with either malaria vaccine alone. Stewart VA; McGrath SM; Dubois PM; Pau MG; Mettens P; Shott J; Cobb M; Burge JR; Larson D; Ware LA; Demoitie MA; Weverling GJ; Bayat B; Custers JH; Dubois MC; Cohen J; Goudsmit J; Heppner DG Infect Immun; 2007 May; 75(5):2283-90. PubMed ID: 17307942 [TBL] [Abstract][Full Text] [Related]
10. Immune responses in mice induced by prime-boost schemes of the Plasmodium falciparum apical membrane antigen 1 (PfAMA1)-based DNA, protein and recombinant modified vaccinia Ankara vaccines. Miao J; Li X; Liu Z; Xue C; Bujard H; Cui L Vaccine; 2006 Sep; 24(37-39):6187-98. PubMed ID: 16806600 [TBL] [Abstract][Full Text] [Related]
11. Enhancing blood-stage malaria subunit vaccine immunogenicity in rhesus macaques by combining adenovirus, poxvirus, and protein-in-adjuvant vaccines. Draper SJ; Biswas S; Spencer AJ; Remarque EJ; Capone S; Naddeo M; Dicks MD; Faber BW; de Cassan SC; Folgori A; Nicosia A; Gilbert SC; Hill AV J Immunol; 2010 Dec; 185(12):7583-95. PubMed ID: 21098232 [TBL] [Abstract][Full Text] [Related]
12. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. Abdulla S; Oberholzer R; Juma O; Kubhoja S; Machera F; Membi C; Omari S; Urassa A; Mshinda H; Jumanne A; Salim N; Shomari M; Aebi T; Schellenberg DM; Carter T; Villafana T; Demoitié MA; Dubois MC; Leach A; Lievens M; Vekemans J; Cohen J; Ballou WR; Tanner M N Engl J Med; 2008 Dec; 359(24):2533-44. PubMed ID: 19064623 [TBL] [Abstract][Full Text] [Related]
13. Four year immunogenicity of the RTS,S/AS02(A) malaria vaccine in Mozambican children during a phase IIb trial. Aide P; Dobaño C; Sacarlal J; Aponte JJ; Mandomando I; Guinovart C; Bassat Q; Renom M; Puyol L; Macete E; Herreros E; Leach A; Dubois MC; Demoitie MA; Lievens M; Vekemans J; Loucq C; Ballou WR; Cohen J; Alonso PL Vaccine; 2011 Aug; 29(35):6059-67. PubMed ID: 21443960 [TBL] [Abstract][Full Text] [Related]
14. Adenovirus-prime and baculovirus-boost heterologous immunization achieves sterile protection against malaria sporozoite challenge in a murine model. Yoshida K; Iyori M; Blagborough AM; Salman AM; Dulal P; Sala KA; Yamamoto DS; Khan SM; Janse CJ; Biswas S; Yoshii T; Yusuf Y; Tokoro M; Hill AVS; Yoshida S Sci Rep; 2018 Mar; 8(1):3896. PubMed ID: 29497047 [TBL] [Abstract][Full Text] [Related]
15. Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B With Chimpanzee Adenovirus 63 and Modified Vaccinia Ankara Vectored Vaccines Expressing ME-TRAP. Rampling T; Ewer KJ; Bowyer G; Bliss CM; Edwards NJ; Wright D; Payne RO; Venkatraman N; de Barra E; Snudden CM; Poulton ID; de Graaf H; Sukhtankar P; Roberts R; Ivinson K; Weltzin R; Rajkumar BY; Wille-Reece U; Lee CK; Ockenhouse CF; Sinden RE; Gerry S; Lawrie AM; Vekemans J; Morelle D; Lievens M; Ballou RW; Cooke GS; Faust SN; Gilbert S; Hill AV J Infect Dis; 2016 Sep; 214(5):772-81. PubMed ID: 27307573 [TBL] [Abstract][Full Text] [Related]
16. Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination with ChAd63 and MVA Encoding ME-TRAP against Plasmodium falciparum Infection in Adults in Senegal. Mensah VA; Gueye A; Ndiaye M; Edwards NJ; Wright D; Anagnostou NA; Syll M; Ndaw A; Abiola A; Bliss C; Gomis JF; Petersen I; Ogwang C; Dieye T; Viebig NK; Lawrie AM; Roberts R; Nicosia A; Faye B; Gaye O; Leroy O; Imoukhuede EB; Ewer KJ; Bejon P; Hill AV; Cisse B; PLoS One; 2016; 11(12):e0167951. PubMed ID: 27978537 [TBL] [Abstract][Full Text] [Related]
17. Immunogenicity when utilizing adenovirus serotype 4 and 5 vaccines expressing circumsporozoite protein in naïve and adenovirus (Ad5) immune mice. Schuldt NJ; Aldhamen YA; Godbehere-Roosa S; Seregin SS; Kousa YA; Amalfitano A Malar J; 2012 Jun; 11():209. PubMed ID: 22720732 [TBL] [Abstract][Full Text] [Related]
19. The dog that did not bark: malaria vaccines without antibodies. Heppner DG; Schwenk RJ; Arnot D; Sauerwein RW; Luty AJ Trends Parasitol; 2007 Jul; 23(7):293-6. PubMed ID: 17512252 [TBL] [Abstract][Full Text] [Related]
20. Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1-4 in Mozambique. Macete E; Aponte JJ; Guinovart C; Sacarlal J; Ofori-Anyinam O; Mandomando I; Espasa M; Bevilacqua C; Leach A; Dubois MC; Heppner DG; Tello L; Milman J; Cohen J; Dubovsky F; Tornieporth N; Thompson R; Alonso PL Trop Med Int Health; 2007 Jan; 12(1):37-46. PubMed ID: 17207146 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]